David Foley has been shortlisted for the KickStart Digital Entrepreneur Award in the Converge Challenge, Scotland’s entrepreneurial development programme, for his proposed company, Elemental Therapeutics. The idea is to develop a new technology to tackle the challenge of oral drug delivery.
When developing a new medicine, it is highly desirable that it can be delivered orally. However, this is a huge challenge, and countless potentially great medicines fail or must be consumed at high doses because they cannot cross the gut wall effectively and get into the bloodstream. Over the past 10 years, our team have been working on a way to target a wide variety of drugs towards a protein that lines the gut wall. This protein allows the drug to be “smuggled” across the gut barrier, offering the potential to resolve the oral drug delivery challenge. Our solution is cost-effective, low-risk and applicable to a wide range of markets. We are especially excited by its potential to deliver peptide drugs; a class of drug notoriously difficult for oral delivery, allowing for full exploitation of this rapidly growing market.
Voting is now open until Monday 19th September at noon. Please support David and cast a vote at the following link:
The two winners will be announced at the Awards Dinner on the evening of September 22nd.